[Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa].
D000547:Amantadine / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D011596:Psychomotor Disorders / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D000547:Amantadine
L'amantadina nel trattamento dell'ipocinesia transitoria di pazienti parkinsoniani in corso di terapia con L-Dopa.